
Merck Group
VerifiedScience and technology in healthcare, life science, performance materials.
Launch date
Employees
Market cap
$229.5b
Net debt
$1.2b
Firm valuation
$241.3b (Public information from Aug 2022)
Share price
$90.59
Darmstadt Hesse (HQ)
Deals in current and previous year:
Corporate Venture Fund: M. Ventures
RELATED LANDSCAPES AND LISTS
Financials
EditUSD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
---|---|---|---|---|---|---|---|
Revenues | - | 40.1b | 42.3b | 46.8b | 48.0b | 48.7b | 57.4b |
% growth | - | - | 5 % | 11 % | 2 % | 1 % | 18 % |
EBITDA | - | 15.1b | 15.8b | 19.6b | 20.6b | 19.8b | 24.0b |
% EBITDA margin | - | 38 % | 37 % | 42 % | 43 % | 41 % | 42 % |
Profit | - | 2.6b | 6.2b | 9.8b | 7.1b | 13.0b | 15.8b |
% profit margin | - | 6 % | 15 % | 21 % | 15 % | 27 % | 28 % |
EV / revenue | - | 4.2x | 5.1x | 5.3x | 4.8x | 4.0x | 3.5x |
EV / EBITDA | - | 11.2x | 13.6x | 12.6x | 11.2x | 10.4x | 8.4x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Merck Group
EditInvestments analysisEdit
By Country
By Industry
Investments by Merck Group
Edit
ACQUISITION by Merck Group Jun 2014

exited

ACQUISITION by Molecular Templates Aug 2017

ACQUISITION by Merck Group Dec 2014

ACQUISITION by Merck Group Dec 2021

ACQUISITION by Merck Group Jan 2022

ACQUISITION by Merck Group Jan 2021